Skip to main content

Advertisement

Log in

Management of Hypertrophic Cardiomyopathy in a Newborn with Dextro-Transposition of the Great Arteries

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Impaired maternal glucose metabolism during pregnancy can have significant effects on the cardiovascular system of the developing fetus. Early in pregnancy the teratogenic effects may lead to structural heart defects, while later in gestation a form of hypertrophic cardiomyopathy can develop due to overgrowth driven by fetal hyperinsulinism. We describe an infant with the uncommon combination of both dextro-transposition of the great arteries and hypertrophic cardiomyopathy. We emphasize the importance of a longitudinal multi-disciplinary approach, from fetal diagnosis to post-operative management, that allowed for an excellent outcome in this rare combination of severe cardiac malformations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wren C, Birrell G, Hawthorne G (2003) Cardiovascular malformations in infants of diabetic mothers. Heart 89(10):1217–1220

    Article  CAS  Google Scholar 

  2. Ferencz C, Neill CA (1992) Cardiomyopathy in infancy: observations in an epidemiologic study. Pediatr Cardiol 13(2):65–71

    Article  CAS  Google Scholar 

  3. Loffredo CA, Wilson PD, Ferencz C (2001) Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64(2):98–106

    Article  CAS  Google Scholar 

  4. Ferencz C (1990) A case-control study of cardiovascular malformation in live born infants: the morphogenic relevance of epidemiological findings, 1st edn. Futura Publishing Company, Mount Kisco

    Google Scholar 

  5. Ullmo S et al (2007) Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J 28(11):1319–1325

    Article  CAS  Google Scholar 

  6. Gutgesell HP, Speer ME, Rosenberg HS (1980) Characterization of the cardiomyopathy in infants of diabetic mothers. Circulation 61(2):441–450

    Article  CAS  Google Scholar 

  7. Weatherall DJ, Ledingham JGG, Warrell DA (1987) Oxford textbook of medicine, 2nd edn. Oxford medical publications Oxford University Press, Oxford, New York

    Google Scholar 

  8. Cedergren MI, Kallen BA (2006) Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defects. Eur J Obstet Gynecol Reprod Biol 125(2):211–216

    Article  Google Scholar 

  9. Mills JL, Baker L, Goldman AS (1979) Malformations in infants of diabetic mothers occur before the seventh gestational week. implications for treatment. Diabetes 28(4):292–293

    Article  CAS  Google Scholar 

  10. Mills JL (1982) Malformations in infants of diabetic mothers. Teratology 25(3):385–394

    Article  CAS  Google Scholar 

  11. Mehta A, Hussain K (2003) Transient hyperinsulinism associated with macrosomia, hypertrophic obstructive cardiomyopathy, hepatomegaly, and nephromegaly. Arch Dis Child 88(9):822–824

    Article  CAS  Google Scholar 

  12. Sardesai MG et al (2001) Fatal hypertrophic cardiomyopathy in the fetus of a woman with diabetes. Obstet Gynecol 98(5 Pt 2):925–927

    CAS  PubMed  Google Scholar 

  13. Chaudhari M, Brodlie M, Hasan A (2008) Hypertrophic cardiomyopathy and transposition of great arteries associated with maternal diabetes and presumed gestational diabetes. Acta Paediatr 97(12):1755–1757

    Article  Google Scholar 

  14. Shu LP et al (2020) Maternal diabetes mellitus and persistent pulmonary hypertension of the newborn: accumulated evidence from observational studies. Can J Diabetes 44(4):327-334 e3

    Article  Google Scholar 

  15. Spoladore R et al (2012) Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence. Eur Heart J 33(14):1724–1733

    Article  CAS  Google Scholar 

  16. Flamm MD, Harrison DC, Hancock EW (1968) Muscular subaortic stenosis. Prevention of outflow obstruction with propranolol. Circulation 38(5):846–858

    Article  CAS  Google Scholar 

  17. Adelman AG et al (1970) Long-term propranolol therapy in muscular subaortic stenosis. Br Heart J 32(6):804–811

    Article  CAS  Google Scholar 

  18. Thompson DS et al (1980) Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J 44(5):488–498

    Article  CAS  Google Scholar 

  19. Way GL et al (1979) The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr 95(6):1020–1025

    Article  CAS  Google Scholar 

  20. Gardiner HM (2015) Prenatal diagnosis of critical isolated congenital heart disease: dismantling silos to provide better care. Ultrasound Obstet Gynecol 45(6):627–628

    Article  CAS  Google Scholar 

  21. Sethi N et al (2021) Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: a model for improving interdisciplinary delivery room care. J Neonatal Perinatal Med 14(3):317–329

    Article  CAS  Google Scholar 

  22. Sanapo L, Moon-Grady AJ, Donofrio MT (2016) Perinatal and delivery management of infants with congenital heart disease. Clin Perinatol 43(1):55–71

    Article  Google Scholar 

  23. Sanapo L et al (2017) Fetal echocardiography for planning perinatal and delivery room care of neonates with congenital heart disease. Echocardiography 34(12):1804–1821

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amee M. Bigelow.

Ethics declarations

Conflict of interest

The authors did not receive support from any organization for the submitted work. The authors have no relevant financial or non-financial conflicts of interests to disclose.

Ethical Approval

The authors have no competing interests to declare that are relevant to the content of this article.

Informed consent

Informed consent was obtained from the parents for submission of the case report to this journal.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bigelow, A.M., Ball, M.K., Galantowicz, M. et al. Management of Hypertrophic Cardiomyopathy in a Newborn with Dextro-Transposition of the Great Arteries. Pediatr Cardiol 43, 926–929 (2022). https://doi.org/10.1007/s00246-022-02874-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-022-02874-4

Keywords

Navigation